Azacitidine (AZC)

DRUG2 trials

Sponsors

Fred Hutchinson Cancer Center, Memorial Sloan Kettering Cancer Center

Conditions

Acute Myeloid Leukemia (AML)Chronic Myelomonocytic LeukemiaMyelodysplastic SyndromeSecondary Myelodysplastic Syndromede Novo Myelodysplastic Syndrome

Phase 2

Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant

CompletedNCT01812252

Fred Hutchinson Cancer CenterChronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome +1

Start: 2013-08-19End: 2022-10-26Updated: 2024-02-15

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

RecruitingNCT06773208

Memorial Sloan Kettering Cancer CenterAcute Myeloid Leukemia (AML)

Start: 2025-01-07End: 2027-01-01Target: 30Updated: 2026-02-24